Stockreport

PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose [Yahoo! Finance]

Phio Pharmaceuticals Corp.  (PHIO) 
Last phio pharmaceuticals corp. earnings: 11/12 07:45 am Check Earnings Report
PDF dose escalation in an early-stage study of the company's investigational skin cancer candidate, PH-762. PH-762 is Phio Pharmaceuticals' lead and only clinical-stage ca [Read more]